About this trial
Exploratory safety and feasibility study of personalized adaptive pudendal neuromodulation for mixed urinary incontinence and extended indications using an implanted (Picostim™ II) system.
Eligibility criteria
Qualifiers
Female. NB: the definition of female refers to sex at birth.
Adult: aged ≥ 22 years (at the time of informed consent signature).
Patient self-reports both stress and urge episodes (clinician-opinion on history taking).
Patient has failed to respond to or could not tolerate conservative treatment as determined by the treating health care provider.
Disqualifiers
Patient is pregnant, breastfeeding, or plans to become pregnant at any time in the future.
Patient is unwilling or unable to use contraception during sexual intercourse for the duration of the study.
In the event that patient becomes pregnant during or after the study, they are not prepared to inactivate device for the whole period of the pregnancy.
Any significant medical condition that, in the opinion of the Investigator, is likely to interfere with study procedures, device operation, or likely to confound evaluation of study endpoints.
Trial design
Treatments tested in this trial
- Pudendal neuromodulation